Cardiovascular immunity refers to the intricate relationship between the immune system and the cardiovascular system, particularly in the context of cardiovascular diseases (CVD). The immune system plays a dual role, acting both as a protective mechanism and contributing to inflammatory processes in the cardiovascular system. Inflammatory responses are integral to the development and progression of CVD, including atherosclerosis, myocardial infarction, and heart failure. Immune cells, such as macrophages and T cells, participate in the formation of atherosclerotic plaques, leading to vessel narrowing and potential blockages. On the protective side, the immune system can help resolve inflammation, repair damaged tissues, and contribute to cardiovascular homeostasis. Dysregulation of this delicate balance can result in chronic inflammation, promoting the pathogenesis of CVD. Research in cardiovascular immunity aims to understand the immune-mediated mechanisms underlying heart diseases, leading to the development of novel therapeutic strategies. Immune-modulating therapies and anti-inflammatory agents are being investigated to target specific pathways involved in cardiovascular inflammation. The intersection of immunology and cardiology highlights the significance of addressing immune responses in the prevention and treatment of cardiovascular diseases, contributing to advancements in both fields for improved patient outcomes.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe